Recorded Chinese product: 盐酸多塞平注射液盐酸多塞平注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司
主要成分Active Ingredients
- 多塞平Duosai Ping
- N-二甲基--二苯并[bErjia Jier Benbing
药物知识说明
多塞平是一种在国家药监局注册认定的药品。该药品含有多塞平-ab05f2f6等成分。
该药品关联的活性成分包括:多塞平Duosai Ping。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司。
您可以探索含有相同成分的其他药品:多塞平-ab05f2f6成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸多塞平注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 多塞平Duosai Ping.
Manufacturers recorded for this product: 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司.
Explore other medicines containing the same ingredient: 多塞平 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸多塞平注射液Recorded Chinese product: 盐酸多塞平注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 1ml:25mg(以多塞平计)Recorded Chinese specification: 1ml:25mg(以多塞平计)
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32022154
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32022154
Manufacturer
Chinese legal name: 徐州莱恩药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32022154
生产企业
徐州莱恩药业有限公司(国产)
适应症
用于治疗抑郁症。
用法用量
病情较重者肌内注射一次25~50mg,一日2次。
不良反应
治疗初期可能出现嗜睡与抗胆碱能反应,如多汗、口干、震颤、眩晕、视物模糊、排尿困难、便秘等。其它有皮疹、体位性低血压,偶见骨髓抑制或中毒性肝损害。可引起注射局部红肿、疼痛、硬结。
禁忌
严重心脏病、近期有心肌梗死发作史、癫痫、青光眼、尿潴留、甲状腺机能亢进、肝功能损害、谵妄、粒细胞减少、对三环类药物过敏者。
注意事项
肝、肾功能严重不全,前列腺肥大、老年或心血管疾患者慎用,使用期间应监测心电图。本品不得与单胺氧化酶抑制剂合用,应在停用单胺氧化酶抑制剂后14天,才能使用本品。患者有转向躁狂倾向时应立即停药。用药期间不宜驾驶车辆、操作机械或高空作业。用药期间应定期检查血象、心、肝、肾功能。
贮藏
密封,置阴凉处。
规格
1ml:25mg(以多塞平计)
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.